ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets branded and generic prescription medications in the United States and Canada. The company focuses on producing controlled substances, oncolytics, hormones, and steroids, with a diverse range of products targeting various health conditions including cancer, hypertension, depression, and pain management, among others. ANI Pharmaceuticals manufactures oral solid dose products, as well as liquids, semi-solids, and topical formulations, including potent products that require specialized manufacturing environments. Additionally, the company provides contract manufacturing services for other pharmaceutical companies. Founded in 2001 and headquartered in Baudette, Minnesota, ANI Pharmaceuticals markets its products through a network of retail pharmacy chains, wholesalers, distributors, and group purchasing organizations, primarily serving the U.S. market.
Novitium Pharma is a pharmaceutical company based in New Jersey that focuses on the development, manufacturing, and distribution of niche generic products. The company offers a diverse commercial product portfolio that includes tablets, oral solutions, capsules, liquids, injections, powders, and gels, catering to the needs of pharmacists, patients, and communities. Novitium is committed to producing affordable, high-quality medications to ensure accessibility for those requiring pharmaceutical care. Through its ongoing investments, the company aims to address various therapeutic categories and dosage forms, fulfilling the evolving needs of the healthcare market.
Since 2001, WellSpring Pharma Services has established itself as a leading pharmaceutical contract manufacturing organization by emphasizing quality, precision and constant improvement. Today, WellSpring provides pharmaceutical manufacturing services for virtually all non-sterile finished dosage form products, such as of solids, semisolids and oral liquids and suspensions, as well as primary and secondary packaging in a variety of presentations.
WellSpring adheres to strict cGMP standards and has an excellent audit history with the US Food and Drug Administration (FDA) and Health Canada.
BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company's products for female sexual health, menopause, contraception and male hypogonadism include LibiGel, a once daily transdermal testosterone gel in Phase III clinical development under a special protocol assessment (SPA) for the treatment of female sexual dysfunction (FSD); Elestrin, a once daily transdermal estradiol (estrogen) gel indicated for the treatment of moderate-to-severe vasomotor symptoms; The Pill-Plus (triple component contraceptive), a once daily use of various combinations of estrogens, progestogens and androgens in development for the treatment of female sexual dysfunction (FSD) in women using oral or transdermal contraceptives, and Bio-T-Gel, a once daily transdermal testosterone gel in development for the treatment of hypogonadism, or testosterone deficiency, in men.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.